Top Markets
Coin of the day
Acura Pharmaceuticals, Inc. Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals, Inc.

ACUR
주식 순위 #41977
Acura Pharmaceuticals, Inc. operates as a drug delivery innovator, dedicated to... Acura Pharmaceuticals, Inc. operates as a drug delivery innovator, dedicated to exploring, developing, and bringing to market novel technologies and products aimed at enhancing medication safety across the United States. Its product portfolio features Oxaydo tablets, a potent Schedule II narcotic prescribed for managing both acute and chronic moderate-to-severe pain. The company also offers the Nexafed line, consisting of pseudoephedrine and acetaminophen tablets, widely utilized as nasal decongestants in a range of over-the-counter and prescription formulations for cold, sinus, and allergy relief. Beyond its current offerings, Acura is actively advancing six additional opioid products through various stages of formulation development. To support its global reach, Acura Pharmaceuticals maintains strategic collaboration and licensing agreements with Egalet US, Inc. and Egalet Ltd. for the worldwide production and commercialization of its Oxaydo products. Furthermore, it has established a development and commercialization partnership with Abuse Deterrent Pharma, LLC to create LTX-03, an immediate-release tablet leveraging the proprietary LIMITx technology. Established in 1935, the company's operations are headquartered in Palatine, Illinois.
주가
$0.0001
마지막 동기화: 2026-08-11
시가총액
$6.60K
변동 (1일)
-50.00%
변동 (1년)
-80.00%
국가
US
거래 Acura Pharmaceuticals, Inc. (ACUR)

카테고리

Acura Pharmaceuticals, Inc. (ACUR)의 주식 분할 이력
Acura Pharmaceuticals, Inc. 주식 (심볼: ACUR)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 13, 2026에 발생했습니다.
Aug 13, 2026 이전에 매수한 ACUR 주식 1주는 현재 0주의 ACUR 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할